CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenue
Total operating revenue	$ 82,035,000	$ 64,977,000	$ 238,451,000	$ 181,059,000
Operating expenses
Goodwill impairment charges	0	0	16,867,000	0
Selling, general and administrative expense	28,205,000	31,963,000	85,761,000	90,117,000
Depreciation and amortization	1,698,000	1,134,000	4,296,000	3,219,000
Total operating expenses	95,960,000	85,074,000	300,181,000	237,931,000
Loss from operations	(13,925,000)	(20,097,000)	(61,730,000)	(56,872,000)
Other non-operating expense (income)
Interest expense	2,695,000	1,497,000	8,017,000	1,632,000
Interest income	(940,000)	0	(3,181,000)	0
Change in fair value of derivative warrant liabilities	203,000	159,000	(58,000)	(445,000)
Change in fair value of earnout liabilities	(23,000)	(3,581,000)	(792,000)	(53,821,000)
Change in fair value of conversion option derivative liabilities	1,284,000	(15,510,000)	(2,034,000)	(15,510,000)
Gain on debt extinguishment	0	0	0	(183,000)
Other, net	140,000	36,000	354,000	172,000
Total other non-operating loss (income)	3,359,000	(17,399,000)	2,306,000	(68,155,000)
(Loss) income before provision for income taxes	(17,284,000)	(2,698,000)	(64,036,000)	11,283,000
Income tax (expense) benefit	(135,000)	24,000	(278,000)	(124,000)
Net (loss) income	$ (17,419,000)	$ (2,674,000)	$ (64,314,000)	$ 11,159,000
Net (loss) income per share attributable to common stockholders:
Basic (in dollars per share)	$ (0.19)	$ (0.03)	$ (0.71)	$ 0.12
Diluted (in dollars per share)	$ (0.19)	$ (0.17)	$ (0.71)	$ (0.03)
Weighted-average number of shares outstanding:
Basic (in shares)	73,469,101	72,184,366	73,679,454	72,807,277
Diluted (in shares)	73,469,101	79,581,304	73,679,454	75,300,018
Patient services
Revenue
Total operating revenue	$ 53,634,000	$ 44,627,000	$ 157,333,000	$ 118,793,000
Operating expenses
Direct costs	44,961,000	36,126,000	132,653,000	96,379,000
Dispensary
Revenue
Total operating revenue	26,792,000	18,839,000	76,228,000	57,736,000
Operating expenses
Direct costs	21,072,000	15,738,000	60,328,000	47,816,000
Clinical trials & other
Revenue
Total operating revenue	1,609,000	1,511,000	4,890,000	4,530,000
Operating expenses
Direct costs	$ 24,000	$ 113,000	$ 276,000	$ 400,000